prof. MUDr. Mgr. Marek Mráz, Ph.D.

2010

• CLL-specific resequencing microarray as a tool for CLL research and diagnostics

  LOCHMANOVÁ Jana TICHÝ Boris PLEVOVÁ Karla DOBEŠ Petr NAVRKALOVÁ Veronika MALČÍKOVÁ Jitka ROČŇOVÁ Ludmila MRÁZ Marek ZELENÝ Jaroslav DVOŘÁKOVÁ Barbora MAYER Jiří TRBUŠEK Martin POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2010, type: Conference abstract

• Detail characterization of 22q11 deletion and miR-650 role in CLL patients

  MRÁZ Marek PLEVOVÁ Karla PAVLOVÁ Šárka TICHÝ Boris STAŇO KOZUBÍK Kateřina TRBUŠEK Martin MAYER Jiří POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2010, type: Conference abstract

• Changes to cell cycle regulating proteins and microRNAs in differentiation of human embryonic stem cells into neural lineage

  DOLEŽALOVÁ Dáša MRÁZ Marek VINARSKÝ Vladimír BÁRTA Tomáš HOLUBCOVÁ Zuzana MALINOVÁ Karla DVOŘÁK Petr POSPÍŠILOVÁ Šárka HAMPL Aleš

  Conference abstract

  Year: 2010, type: Conference abstract

• Interactions with the microenvironment protect lymphoma B-cells from rituximab induced apoptosis and could represent a therapeutic target.

  MRÁZ Marek ZENT Clive CHURCH Amy BAIG Nisar JELINEK Diane WU X. POSPÍŠILOVÁ Šárka ANSELL Stephen NOVAK Anne WITZIG Thomas NOWAKOWSKI Grzegorz

  Conference abstract

  Year: 2010, type: Conference abstract

• Manipulation of gene expression in chronic lymphocytic leukemia cells in vitro

  PAVLOVÁ Šárka KAUCKA M. MRÁZ Marek PLEVOVÁ Karla VERNER Jan BRYJA Vítězslav POSPÍŠILOVÁ Šárka

  Conference abstract

  Year: 2010, type: Conference abstract

• MicroRNA v patogenezi chronické lymfocytární leukemie a jejich prognostický význam

  MRÁZ Marek POSPÍŠILOVÁ Šárka MAYER Jiří

  Article in Periodical

  Transfuze a hematologie dnes, year: 2010, volume: 16, edition: Suppl. 1

• Molekulární patogeneze chronické lymfocytární leukemie

  MRÁZ Marek PAVLOVÁ Šárka MALČÍKOVÁ Jitka PLEVOVÁ Karla MAYER Jiří POSPÍŠILOVÁ Šárka

  Article in Periodical

  Transfuze a hematologie dnes, year: 2010, volume: 16, edition: suppl. 1

• Pathogenesis of CLL

  MRÁZ Marek TRBUŠEK Martin

  Year: 2010, type:

• Rearrangement of lambda immunoglobulin light chain in CLL is coupled with expression of miRNA-650

  MRÁZ Marek

  Year: 2010, type:

• Targeting integrin/CD49D/VLA-4 with natalizumab can inhibit adhesion of malignant B cells and sensitize them to chemoimmunotherapy

  MRÁZ Marek ZENT C. CHURCH A. JELINEK D. POSPÍŠILOVÁ Šárka ANSELL S. NOVAK A. WITZIG T. NOWAKOWSKI G.

  Conference abstract

  Year: 2010, type: Conference abstract